A Multicenter Retrospective Chart Review Study of Treatment and Disease Patterns and Clinical Outcomes of Patients with Chronic-Phase Chronic Myeloid Leukemia in Third-Line Treatment or with T315I Mutation.

Nicolini, Franck-Emmanuel; Huguet, Françoise; Huynh, Lynn; Xu, Churong; Bouvier, Christophe; Yocolly, Aurore; Etienne, Gabriel

Nicolini, Franck-Emmanuel; Huguet, Françoise; Huynh, Lynn; Xu, Churong; Bouvier, Christophe; Yocolly, Aurore; Etienne, Gabriel.

Afiliación

Nicolini FE; Centre Léon Bérard, 69373 Lyon, France.
Huguet F; Fi-LMC Group, 69437 Lyon, France.
Huynh L; Fi-LMC Group, 69437 Lyon, France.
Xu C; Hématologie, Institut Universitaire du Cancer de Toulose-Oncopole, 31100 Toulouse, France.
Bouvier C; Analysis Group, Inc., Boston, MA 02199, USA.
Yocolly A; Analysis Group, Inc., Los Angeles, CA 90071, USA.
Etienne G; Centre Léon Bérard, 69373 Lyon, France.

Cancers (Basel) ; 15(16)2023 Aug 18.

Article en En | MEDLINE | ID: mdl-37627189

Palabras clave

T315I mutation; chronic-phase chronic myeloid leukemia (CML-CP); overall survival; treatment patterns; tyrosine kinase inhibitor (TKI)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google